KARI NOTHSTINE: Open Payments
NPI 1598485229 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 35 payments from 15 companies in 2025. Trend: 2023 $459 · 2024 $894 · 2025 $1,011
Food & beverage: $939Education: $72
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $441 |
| E.R. Squibb & Sons, L.L.C. | 2 | $95 |
| Kerecis Limited | 3 | $75 |
| ConvaTec Inc. | 1 | $66 |
| Janssen Biotech, Inc. | 2 | $53 |
| Galderma Laboratories, L.P. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| LEO Pharma Inc. | 1 | $28 |
Products named: SKYRIZI, Sotyktu, Kerecis SurgiClose, INNOVAMATRIX AC, TREMFYA, NEMLUVIO, COSENTYX, ILUMYA.
Industry payments across MI — which companies pay providers there.
